Could a bone drug ease CRPS pain? large trial underway
Symptom relief
Recruiting now
This phase 3 trial tests whether the drug neridronate, given as four IV infusions over 10 days, can reduce pain and other symptoms of complex regional pain syndrome type 1 (CRPS-1). About 270 adults with CRPS in one limb will receive either the drug or a placebo. The main goal is…
Phase: PHASE3 • Sponsor: Ambros Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 07:00 UTC